Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners.

Yu SH, Boyce M, Wands AM, Bond MR, Bertozzi CR, Kohler JJ.

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4834-9. doi: 10.1073/pnas.1114356109. Epub 2012 Mar 12.

PMID:
22411826
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.

Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW.

Mol Cell Proteomics. 2002 Oct;1(10):791-804.

PMID:
12438562
[PubMed - indexed for MEDLINE]
Free Article
3.

Global identification of O-GlcNAc-modified proteins.

Nandi A, Sprung R, Barma DK, Zhao Y, Kim SC, Falck JR, Zhao Y.

Anal Chem. 2006 Jan 15;78(2):452-8.

PMID:
16408927
[PubMed - indexed for MEDLINE]
4.

Glycosylation of the nuclear pore.

Li B, Kohler JJ.

Traffic. 2014 Apr;15(4):347-61. doi: 10.1111/tra.12150. Epub 2014 Feb 13.

PMID:
24423194
[PubMed - in process]
5.

Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.

Alfaro JF, Gong CX, Monroe ME, Aldrich JT, Clauss TR, Purvine SO, Wang Z, Camp DG 2nd, Shabanowitz J, Stanley P, Hart GW, Hunt DF, Yang F, Smith RD.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7280-5. doi: 10.1073/pnas.1200425109. Epub 2012 Apr 19.

PMID:
22517741
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Oxidative stress inhibits nuclear protein export by multiple mechanisms that target FG nucleoporins and Crm1.

Crampton N, Kodiha M, Shrivastava S, Umar R, Stochaj U.

Mol Biol Cell. 2009 Dec;20(24):5106-16. doi: 10.1091/mbc.E09-05-0397. Epub .

PMID:
19828735
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.

Goodwin OY, Thomasson MS, Lin AJ, Sweeney MM, Macnaughtan MA.

J Biotechnol. 2013 Dec;168(4):315-23. doi: 10.1016/j.jbiotec.2013.10.008. Epub 2013 Oct 16.

PMID:
24140293
[PubMed - indexed for MEDLINE]
8.

Quantitative regulation of nuclear pore complex proteins by O-GlcNAcylation.

Mizuguchi-Hata C, Ogawa Y, Oka M, Yoneda Y.

Biochim Biophys Acta. 2013 Dec;1833(12):2682-9. doi: 10.1016/j.bbamcr.2013.06.008. Epub 2013 Jun 15.

PMID:
23777819
[PubMed - indexed for MEDLINE]
9.

O-GlcNAc: a regulatory post-translational modification.

Wells L, Whelan SA, Hart GW.

Biochem Biophys Res Commun. 2003 Mar 14;302(3):435-41. Review.

PMID:
12615051
[PubMed - indexed for MEDLINE]
10.

Detecting the "O-GlcNAc-ome"; detection, purification, and analysis of O-GlcNAc modified proteins.

Zachara NE.

Methods Mol Biol. 2009;534:251-79. doi: 10.1007/978-1-59745-022-5_19. Review.

PMID:
19277546
[PubMed - indexed for MEDLINE]
11.

Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.

Shen DL, Gloster TM, Yuzwa SA, Vocadlo DJ.

J Biol Chem. 2012 May 4;287(19):15395-408. doi: 10.1074/jbc.M111.310664. Epub 2012 Feb 6.

PMID:
22311971
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar.

Wells L, Hart GW.

FEBS Lett. 2003 Jul 3;546(1):154-8. Review.

PMID:
12829252
[PubMed - indexed for MEDLINE]
Free Article
13.

Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.

Hahne H, Moghaddas Gholami A, Kuster B.

Mol Cell Proteomics. 2012 Oct;11(10):843-50. Epub 2012 Jun 1.

PMID:
22661428
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Modulation of transcription factor function by O-GlcNAc modification.

Ozcan S, Andrali SS, Cantrell JE.

Biochim Biophys Acta. 2010 May-Jun;1799(5-6):353-64. doi: 10.1016/j.bbagrm.2010.02.005. Epub 2010 Mar 2. Review.

PMID:
20202486
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1.

Ball LE, Berkaw MN, Buse MG.

Mol Cell Proteomics. 2006 Feb;5(2):313-23. Epub 2005 Oct 22.

PMID:
16244361
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs.

Klein AL, Berkaw MN, Buse MG, Ball LE.

Mol Cell Proteomics. 2009 Dec;8(12):2733-45. doi: 10.1074/mcp.M900207-MCP200. Epub 2009 Aug 11.

PMID:
19671924
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway.

Boyce M, Carrico IS, Ganguli AS, Yu SH, Hangauer MJ, Hubbard SC, Kohler JJ, Bertozzi CR.

Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3141-6. doi: 10.1073/pnas.1010045108. Epub 2011 Feb 7.

PMID:
21300897
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

O-GlcNAc modification affects the ATM-mediated DNA damage response.

Miura Y, Sakurai Y, Endo T.

Biochim Biophys Acta. 2012 Oct;1820(10):1678-85. doi: 10.1016/j.bbagen.2012.06.013. Epub 2012 Jul 1.

PMID:
22759405
[PubMed - indexed for MEDLINE]
Free Article
19.

A chemical approach for identifying O-GlcNAc-modified proteins in cells.

Vocadlo DJ, Hang HC, Kim EJ, Hanover JA, Bertozzi CR.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9116-21. Epub 2003 Jul 21.

PMID:
12874386
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Antibodies that detect O-linked β-D-N-acetylglucosamine on the extracellular domain of cell surface glycoproteins.

Tashima Y, Stanley P.

J Biol Chem. 2014 Apr 18;289(16):11132-42. doi: 10.1074/jbc.M113.492512. Epub 2014 Feb 26.

PMID:
24573683
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk